Details for Patent: RE49556
✉ Email this page to a colleague
Which drugs does patent RE49556 protect, and when does it expire?
Patent RE49556 protects BRAFTOVI and is included in one NDA.
This patent has seventy-five patent family members in forty-nine countries.
Summary for Patent: RE49556
| Title: | Compounds and compositions as protein kinase inhibitors |
| Abstract: | The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf. |
| Inventor(s): | Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan, Xing Wang, Yongping Xie |
| Assignee: | Array Biopharma Inc |
| Application Number: | US17/376,199 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent RE49556 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent RE49556
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-002 | Jun 27, 2018 | RX | Yes | Yes | RE49556 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE49556
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2470526 | ⤷ Start Trial | PA2019005 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2727918 | ⤷ Start Trial | PA2019006 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2470526 | ⤷ Start Trial | 300973 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2727918 | ⤷ Start Trial | 300975 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2470526 | ⤷ Start Trial | LUC00101 | Luxembourg | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
